32531194|t|Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids.
32531194|a|Retinal ganglion cells (RGCs) serve as the connection between the eye and the brain, with this connection disrupted in glaucoma. Numerous cellular mechanisms have been associated with glaucomatous neurodegeneration, and useful cellular models of glaucoma allow for the precise analysis of degenerative phenotypes. Human pluripotent stem cells (hPSCs) serve as powerful tools for studying human disease, particularly cellular mechanisms underlying neurodegeneration. Thus, efforts focused upon hPSCs with an E50K mutation in the Optineurin (OPTN) gene, a leading cause of inherited forms of glaucoma. CRISPR/Cas9 gene editing introduced the OPTN(E50K) mutation into existing lines of hPSCs, as well as generating isogenic controls from patient-derived lines. RGCs differentiated from OPTN(E50K) hPSCs exhibited numerous neurodegenerative deficits, including neurite retraction, autophagy dysfunction, apoptosis, and increased excitability. These results demonstrate the utility of OPTN(E50K) RGCs as an in vitro model of neurodegeneration, with the opportunity to develop novel therapeutic approaches for glaucoma.
32531194	30	38	Glaucoma	Disease	MESH:D005901
32531194	39	43	OPTN	Gene	10133
32531194	44	48	E50K	ProteinMutation	tmVar:p|SUB|E|50|K;HGVS:p.E50K;VariantGroup:0;CorrespondingGene:10133;RS#:28939688;CorrespondingSpecies:9606;CA#:118628
32531194	270	278	glaucoma	Disease	MESH:D005901
32531194	335	365	glaucomatous neurodegeneration	Disease	MESH:D019636
32531194	394	405	of glaucoma	Disease	MESH:D005901
32531194	465	470	Human	Species	9606
32531194	539	544	human	Species	9606
32531194	598	615	neurodegeneration	Disease	MESH:D019636
32531194	658	662	E50K	ProteinMutation	tmVar:p|SUB|E|50|K;HGVS:p.E50K;VariantGroup:0;CorrespondingGene:10133;RS#:28939688;CorrespondingSpecies:9606;CA#:118628
32531194	679	689	Optineurin	Gene	10133
32531194	691	695	OPTN	Gene	10133
32531194	738	749	of glaucoma	Disease	MESH:D005901
32531194	791	795	OPTN	Gene	10133
32531194	796	800	E50K	ProteinMutation	tmVar:p|SUB|E|50|K;HGVS:p.E50K;VariantGroup:0;CorrespondingGene:10133;RS#:28939688;CorrespondingSpecies:9606;CA#:118628
32531194	886	893	patient	Species	9606
32531194	934	938	OPTN	Gene	10133
32531194	939	943	E50K	ProteinMutation	tmVar:p|SUB|E|50|K;HGVS:p.E50K;VariantGroup:0;CorrespondingGene:10133;RS#:28939688;CorrespondingSpecies:9606;CA#:118628
32531194	970	996	neurodegenerative deficits	Disease	MESH:D019636
32531194	1131	1135	OPTN	Gene	10133
32531194	1136	1140	E50K	ProteinMutation	tmVar:p|SUB|E|50|K;HGVS:p.E50K;VariantGroup:0;CorrespondingGene:10133;RS#:28939688;CorrespondingSpecies:9606;CA#:118628
32531194	1171	1188	neurodegeneration	Disease	MESH:D019636
32531194	1255	1263	glaucoma	Disease	MESH:D005901
32531194	Positive_Correlation	MESH:D019636	RS#:28939688;HGVS:p.E50K;CorrespondingGene:10133
32531194	Association	MESH:D005901	10133
32531194	Association	MESH:D005901	RS#:28939688;HGVS:p.E50K;CorrespondingGene:10133
32531194	Association	MESH:D019636	10133
32531194	Association	MESH:D019636	10133
32531194	Association	MESH:D005901	10133

